Source

Recombinant gene engineering production, E. coli expression.

Product Introduction

Recombinant human insulin is human insulin expressed through genetic engineering. The protein is expressed by Escherichia coli, purified, and obtained with high purity and low immunogenicity. It can be used as an additive to various cell culture media to improve cell growth systems and increase the expression of target proteins.

Product characteristics

• Product origin: E. coli
• Product appearance: white or off-white powder
• Activity: ≥25U/mg
• Purity (HPLC): ≥97%
• Bioburden: ≤300cfu/mg
• Endotoxin content: ≤25EU/mg

Product features

• Easy to use: can be dissolved in PBS, purified water, etc.
• No animal origin: produced by recombination, free of exogenous viral contamination, and no animal-derived materials are used in the production process.
• Quality stability: mass production can ensure stable and continuous batch production; small batch-to-batch differences and stable quality.
• Complies with regulatory requirements: production equipment and production environment meet relevant regulatory requirements, and the production process complies with GMP guidelines.

Related products（For more detailed information, please contact us）

hEGF, FGF2, IGF-1, LR3, Transferrin, Noggin